Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States Denosumab is widely used in the treatment of bone metastases ...
Machine learning (ML) is a subset of artificial intelligence (AI) that involves using algorithms and statistical models to enable computer systems to learn from data and improve performance on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results